Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1999
10/14/1999CA2325995A1 Antagonists of gonadotropin releasing hormone
10/14/1999CA2325948A1 Treatment of panic attacks
10/14/1999CA2325523A1 Prodrugs of phosphorous-containing pharmaceuticals
10/14/1999CA2325400A1 Device for the transdermal delivery of diclofenac
10/14/1999CA2324976A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof
10/14/1999CA2324931A1 Novel nucleic acid transfer agents, compositions containing same and uses
10/14/1999CA2323965A1 Process for the production of purine derivatives
10/14/1999CA2317572A1 Pharmaceutical compositions and methods for use
10/14/1999CA2317570A1 Pharmaceutical compositions and methods of use
10/14/1999CA2317567A1 Pharmaceutical compositions and methods for use
10/14/1999CA2315946A1 Novel local anesthetic compounds and uses
10/14/1999CA2269050A1 Method for transdermal administration of gp iib/iiia antagonist
10/13/1999EP0949332A2 HSSCRG1 polypeptides
10/13/1999EP0949258A1 Alpha-lipoic acid in crystalline form
10/13/1999EP0949250A1 Process for manufacturing alpha1L-adrenoceptor antagonists
10/13/1999EP0949249A1 Process for producing imidazole derivatives
10/13/1999EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999EP0949242A1 Aromatic amine derivatives having nos inhibitory effect
10/13/1999EP0949203A1 Fine cisplatin powder and process for the production thereof
10/13/1999EP0948968A1 Therapeutic agents interfering in neutrophil migration
10/13/1999EP0948967A2 Treatment of viral disease in swine
10/13/1999EP0948965A1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives
10/13/1999EP0948963A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
10/13/1999EP0948646A1 Methods for identifying genes essential to the growth of an organism
10/13/1999EP0948622A1 Human mage-like protein
10/13/1999EP0948616A2 Riboflavin mutants as vaccines against actinobacillus pleuropneumoniae
10/13/1999EP0948522A1 Therapeutic and diagnostic agents capable of modulating cellular responsiveness to cytokines
10/13/1999EP0948521A1 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
10/13/1999EP0948520A1 Tissue specific expression of retinoblastoma protein
10/13/1999EP0948518A1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
10/13/1999EP0948515A1 Human b-cell translocation genes-2 and 3
10/13/1999EP0948511A2 Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948509A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/13/1999EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999EP0948499A1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
10/13/1999EP0948498A1 Sulfonamide compounds having 5-ht receptor activity
10/13/1999EP0948497A2 Substituted pyrimidine compounds and their use
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948494A1 Substituted benzo 1,4]dioxanes as antiobesity agents
10/13/1999EP0948493A1 Indene inhibitors of cox-2
10/13/1999EP0948491A1 Aminothiazole derivatives useful in the preparation of beta-lactam antibiotics
10/13/1999EP0948489A1 Piperazine compounds as inhibitors of mmp or tnf
10/13/1999EP0948483A1 Farnesyl transferase inhibitors
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948359A1 Compositions containing lipophilic oligosaccharide antibiotic and albumin
10/13/1999EP0948357A1 Use of low molecular weight amino alcohols in ophthalmic compositions
10/13/1999EP0948348A1 Manipulation of non-terminally differentiated cells using the notch pathway
10/13/1999EP0948341A1 Phospholipid drug derivatives
10/13/1999EP0948340A1 Biologically active substances, method for obtaining and compositions containing them
10/13/1999EP0948336A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size
10/13/1999EP0948335A1 Methods of treating or preventing cardiac arrhythmia
10/13/1999EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues
10/13/1999EP0948333A1 Use of a combination of carbonic anhydrase inhibitors and prostaglandins for treating glaucoma
10/13/1999EP0948332A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
10/13/1999EP0948331A2 Method for treating multiple sclerosis
10/13/1999EP0948330A1 Il-8 receptor antagonists
10/13/1999EP0948329A1 Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
10/13/1999EP0948328A1 Compositions based on aminoacids
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999EP0948325A2 Lamotrigine in the treatment and prophylaxis of migraine
10/13/1999EP0948324A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth
10/13/1999EP0948320A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
10/13/1999EP0948317A1 Dispersible macromolecule compositions and methods for their preparation and use
10/13/1999EP0948265A1 A method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof
10/13/1999EP0948258A1 Brain targeted low molecular weight hydrophobic antioxidant compounds
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0948256A1 Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral rna
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0850300B1 Method of modulating gene expression with reduced immunostimulatory response
10/13/1999EP0817780B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/13/1999EP0783486B1 Novel prostaglandin synthase inhibitors
10/13/1999EP0775339B1 Current-to-pressure transducer with selectable, adjustable input filter
10/13/1999EP0740654B1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
10/13/1999EP0722453B1 Process and antiparasitic intermediates for doramectin
10/13/1999EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas
10/13/1999EP0695185B1 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
10/13/1999EP0693479B1 Aconitine-like compound and antipyretic analgesic anti-inflammatory agent
10/13/1999EP0672192B1 Method for inhibition of viral morphogenesis
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999EP0658111B1 Methods for enhancing drug delivery with modified saponins
10/13/1999EP0646116B1 Process and intermediates for bis-aza-bicyclic anxiolytic agents
10/13/1999EP0627915B1 Sprayable analgesic composition and method of use
10/13/1999EP0579618B1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/13/1999EP0574457B1 Antiviral nucleoside combination
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999EP0540609B1 Cephalosporins and homologues, preparations and pharmaceutical compositions
10/13/1999EP0489153B1 Vaccine compositions containing liposomes
10/13/1999CN1231802A Method for adapting a receiver to transmission conditions, and the adequate receiver
10/13/1999CN1231700A Loxoprofen-containing preparation for external use
10/13/1999CN1231694A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
10/13/1999CN1231670A 7 'alpha'-('xi'-aminoalkyl) estratrienes, process for preparing the same, pharmaceutical preparations containing the same, and their use for preparing medicaments
10/13/1999CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999CN1231665A Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231661A Aralkyl and aralkylidene heterocyclic lactams and imides
10/13/1999CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
1 ... 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 ... 7860